AI assistant
Sending…
IMMUCELL CORP /DE/ — Director's Dealing 2011
Aug 23, 2011
34519_dirs_2011-08-23_930d1564-1c53-431a-9434-ccf2d61dbd1c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2011-08-19
Reporting Person: Tomsche David Scott (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-08-19 | Common Stock, par value $0.10 per share | P | 15000 | $5.8 | Acquired | 52668 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-08-19 | Incentive Stock Options (Right to Buy) | $5.8 | X | 15000 | Disposed | 2011-12-20 | Common Stock (15000) | Direct |
Footnotes
F1: Exercisable as to 5,000 shares on and after June 8, 2007 and an additional 5,000 shares on and after June 7, 2008 and the remaining 5,000 shares on and after June 13, 2009.
More from IMMUCELL CORP /DE/
Regulatory Filings
2026
May 14
Annual Report
2026
May 13
Regulatory Filings
2026
May 8
Proxy Solicitation & Information Statement
2026
Apr 24
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 8
Annual Report
2026
Mar 30
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 23